TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 242 filers reported holding TG THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $345,669 | -50.0% | 41,348 | +48.6% | 0.00% | – |
Q2 2023 | $691,098 | +189.9% | 27,822 | +75.5% | 0.00% | – |
Q1 2023 | $238,369 | +92.7% | 15,849 | +51.6% | 0.00% | – |
Q4 2022 | $123,683 | -56.6% | 10,455 | +21.9% | 0.00% | – |
Q3 2021 | $285,000 | -40.9% | 8,574 | -31.0% | 0.00% | – |
Q2 2021 | $482,000 | -8.4% | 12,421 | +13.9% | 0.00% | – |
Q1 2021 | $526,000 | +49.9% | 10,908 | +61.5% | 0.00% | – |
Q4 2020 | $351,000 | – | 6,754 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |